Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gram

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 1997
The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitorsJ Sidelmann, J Jespersen, C Kluft, et al.
The European Respiratory Journal|May 10, 2002
Effect of inhaled heparin on lung function and coagulation in healthy volunteersK E Bendstrup, J Gram, J I Jensen
Bone|April 1, 1995
Autosomal dominant osteopetrosis: bone mineral measurements of the entire skeleton of adults in two different subtypesE Grodum, J Gram, K Brixen, et al.
American Journal of Clinical Pathology|June 1, 1985
Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-IIIJ Jespersen, J Gram, C Kluft, et al.
Journal of Internal Medicine|October 1, 1990
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endotheliumS Munkvad, J Jespersen, J Gram, et al.
Journal of the American College of Cardiology|August 1, 1991
Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapyS Munkvad, J Jespersen, J Gram, et al.
Journal of the American College of Cardiology|March 15, 1991
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled studyS Munkvad, J Jespersen, J Gram, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal womenJ S Madsen, S R Kristensen, J Gram, et al.
Acta Endocrinologica|December 1, 1991
Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteersJ Gram, J Bollerslev, H K Nielsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1995
The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serumE M Bladbjerg, K Overgaard, J Gram, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 1997
The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitorsJ Sidelmann, J Jespersen, C Kluft, et al.
The European Respiratory Journal|May 10, 2002
Effect of inhaled heparin on lung function and coagulation in healthy volunteersK E Bendstrup, J Gram, J I Jensen
Bone|April 1, 1995
Autosomal dominant osteopetrosis: bone mineral measurements of the entire skeleton of adults in two different subtypesE Grodum, J Gram, K Brixen, et al.
American Journal of Clinical Pathology|June 1, 1985
Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-IIIJ Jespersen, J Gram, C Kluft, et al.
Journal of Internal Medicine|October 1, 1990
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endotheliumS Munkvad, J Jespersen, J Gram, et al.
Journal of the American College of Cardiology|August 1, 1991
Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapyS Munkvad, J Jespersen, J Gram, et al.
Journal of the American College of Cardiology|March 15, 1991
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled studyS Munkvad, J Jespersen, J Gram, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal womenJ S Madsen, S R Kristensen, J Gram, et al.
Acta Endocrinologica|December 1, 1991
Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteersJ Gram, J Bollerslev, H K Nielsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1995
The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serumE M Bladbjerg, K Overgaard, J Gram, et al.
Pageof 15